ABCG2 loss-of-function polymorphism predicts poor response to allopurinol in patients with gout-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

ABCG2 loss-of-function polymorphism predicts poor response to allopurinol in patients with gout

Published:2016-01-26 Issue:2 Volume:17 Page:201-203
ISSN:1470-269X
Container-title:The Pharmacogenomics Journal
language:en
Short-container-title:Pharmacogenomics J

Author:

Roberts R L,Wallace M C,Phipps-Green A J,Topless R,Drake J M,Tan P,Dalbeth N,Merriman T R,Stamp L K

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,Genetics,Molecular Medicine

Link

https://www.nature.com/articles/tpj2015101.pdf

Reference10 articles.

1. Khanna D, Fitzgerald J, Khanna P, Sangmee B, Singh M, Neogi T et al. 2012 American College of Rheumatology Guidelines for the Management of Gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricaemia. Arthritis Care Res 2012; 64: 1431–1446.

2. Stamp L, Merriman T, Barclay M, Singh J, Roberts R, Wright D et al. Inadequate response to allopurinol in the treatment of gout – defining the population and potential causes. Semin Arthritis Rheum 2014; 44: 170–174.

3. Graham G, Kannangara D, Stocker S, Portek I, Pile K, Indraratna P et al. Understanding the dose-response relationship of allopurinol: predicting the optimal dosage. Br J Clin Pharmacol 2013; 76: 932–938.

4. Roberts R, Stamp L . Pharmacogenetic considerations in the treatment of gout. Pharmacogenetics 2015; 16: 619–629.

5. Saito Y, Stamp L, Caudle K, Hershfield M, McDonagh M, Callaghan J et al. Clinical pharmacogenetics implementation consortium (CPIC) guidelines for human leukocyte antigen B (HLA-B) genotype and allopurinol dosing: 2015 update. Clin Pharm Ther 2016; 99: 36–37.

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early-onset gout;Joint Bone Spine;2024-09

2. A Genome-Wide Association Study of Oxypurinol Concentrations in Patients Treated with Allopurinol;Journal of Personalized Medicine;2024-06-18

3. Moving urate-lowering therapy in gout beyond guideline recommendations;Seminars in Arthritis and Rheumatism;2024-04

4. Building capacity to conduct genetic epidemiology research on hyperuricaemia and gout in an Indigenous community in Guam;2024-02-22

5. The development and evaluation of dose‐prediction tools for allopurinol therapy (Easy‐Allo tools);British Journal of Clinical Pharmacology;2024-02-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3